Radiopharm Theranostics Ltd. - Form 6-K Summary (Nov 2025)

The Company submitted this Form 6-K solely to report a material event disclosed to the Australian Securities Exchange (ASX).

• Material Event: Publication of a Notice of Extraordinary General Meeting (EGM) and Proxy Form on November 4, 2025.

Investors should immediately review Exhibit 99.1 to determine the specific proposals or resolutions slated for shareholder vote at the upcoming EGM.

This filing contains no new financial performance metrics, strategic guidance, or risk factor updates outside of the EGM docum